Skip to main content
SpringerLink
Log in

PET Imaging of Dementia

  • Conference paper
Diseases of the Brain, Head & Neck, Spine 2012–2015

Abstract

In the medical dictionary, dementia is defined in the following way: “Dementia is a loss of mental ability severe enough to interfere with normal activities of daily living, lasting more than six months, not present since birth, and not associated with a loss or alteration of consciousness”. Dementia is usually caused by neurodegenerative diseases, e.g., Alzheimer’s disease (AD), frontotemporal lobar degeneration (FTLD), dementia with Lewy bodies (DLB) or vascular lesions. However, some psychiatric syndromes, e.g., severe major depression (MD) and severe metabolic abnormalities, e.g., serious hypothyroidism, can mimic dementia. Specific organic disorders, e.g., multiple sclerosis, AIDS, prolonged abuse of alcohol or other drugs, may also cause dementias. In the daily routine of a positron-emission tomography (PET) center, patients with dementia or questionable dementia caused by neurodegenerative disorders have been examined.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Herholz K, Carter SF, Jones M (2007) Positron emission tomography imaging in dementia. Br J Radiol 80:S160–167

    Article  PubMed  Google Scholar 

  2. Drzezga A (2010) Amyloid-plaque imaging in early and differential diagnosis of dementia. Ann Nucl Med 24:55–66

    Article  PubMed  Google Scholar 

  3. Lesné S, Koh MT, Kotilinek L et al (2006) A specific amyloidbeta protein assembly in the brain impairs memory. Nature 440:352–357

    Article  PubMed  Google Scholar 

  4. Walsh DM, Selkoe DJ (2004) Deciphering the Molecular Basis of Memory Failure in Alzheimer’s Disease. Neuron 44:181–193

    Article  PubMed  CAS  Google Scholar 

  5. Bao F, Wicklund L, Lacor PN et al (2011) Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity. Neurobiol Aging [Epub ahead of print]

    Google Scholar 

  6. Drzezga A (2008) Basic pathologies of neurodegenerative dementias and their relevance for state-of-the-art molecular imaging studies. Eur J Nucl Med Mol Imaging 35:S4–S11

    Article  PubMed  Google Scholar 

  7. Bartus RT, Dean RL, Beer B et al (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–414

    Article  PubMed  CAS  Google Scholar 

  8. Nordberg A, Hartvig P, Lilja A et al (1990) Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography. J Neural Transm Park Dis Dement 2:215–224

    Article  CAS  Google Scholar 

  9. Nyback H, Halldin C, Ahlin A et al (1994) PET studies of the uptake of (S)-[C-11]nicotine and (R)-[C-11]nicotine in the human brain — difficulties in visualizing specific receptor-binding in-vivo. Psychopharmacology 115:31–36

    Article  PubMed  CAS  Google Scholar 

  10. Sabri O, Kendziorra K, Wolf H et al (2008) Acetylcholine receptors in dementia and mild cognitive impairment. Eur J Nucl Med Mol Imaging 35:S30–S45

    Article  PubMed  CAS  Google Scholar 

  11. Kendziorra K, Wolf H, Meyer PM et al (2011) Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography. Eur J Nucl Med Mol Imaging 38:515–525

    Article  PubMed  CAS  Google Scholar 

  12. Sabri O, Wilke S, Graef S et al (2011) Cerebral alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in early Alzheimer disease (AD) assessed with the new PET tracer (-)-[18F]-norchloro-fluoro-homoepibatidine (NCFHEB). J Nucl Med 52:1267

    Google Scholar 

  13. Berti V, Pupi A, Mosconi L (2011) PET/CT in diagnosis of dementia. Ann NY Acad Sci 1228:81–92

    Article  PubMed  CAS  Google Scholar 

  14. Small GW, Kepe V, Ercoli LM et al (2006) PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 355:2652–2663

    Article  PubMed  CAS  Google Scholar 

  15. Barthel H, Gertz HJ, Dresel S et al, for the Florbetaben Study Group (2011) Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer’s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol 10:424–435

    Google Scholar 

  16. Vandenberghe R, Van Laere K, Ivanoiu A et al (2010) 18Fflutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol. 68(3):319–329

    Article  PubMed  Google Scholar 

  17. Cirrito JR, Disabato BM, Restivo JL et al (2011) Serotonin signaling is associated with lower amyloid-ß levels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A 108:14968–14973

    Article  PubMed  CAS  Google Scholar 

  18. Schroeter ML, Raczka K, Neumann J et al (2007) Towards a nosology for frontotemporal lobar degenerations — a metaanalysis involving 267 subjects. Neuroimage 36:497–510

    Article  PubMed  Google Scholar 

  19. Franceschi M, Anchisi D, Pelati O et al (2005) Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Ann Neurol 57:216–225

    Article  PubMed  CAS  Google Scholar 

  20. Edison P, Rowe CC, Rinne JO et al (2008) Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 79:1331–1338

    Article  PubMed  CAS  Google Scholar 

  21. Yong SW, Yoon JK, An YS, Lee PH (2007) A comparison of cerebral glucose metabolism in Parkinson’s disease, Parkinson’s disease dementia and dementia with Lewy bodies. Eur J Neurol 14:1357–1362

    Article  PubMed  CAS  Google Scholar 

  22. O’Brien JT, Colloby SJ, Pakrasi S et al (2008) Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations. Neuroimage 40:1056–1063

    Article  PubMed  Google Scholar 

  23. Brown RG, Lacomblez L, Landwehrmeyer BG et al (2010) Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 133:2382–2393

    Article  PubMed  Google Scholar 

  24. Teune LK, Bartels AL, de Jong BM et al (2010) Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord 25:2395–2404

    Article  PubMed  Google Scholar 

  25. Eckert T, Tang C, Ma Y et al (2008) Abnormal metabolic networks in atypical parkinsonism. Mov Disord 23:727–733

    Article  PubMed  Google Scholar 

  26. Mahapatra RK, Edwards MJ, Schott JM et al (2004) Corticobasal degeneration. Lancet Neurol 3:736–743

    Article  PubMed  Google Scholar 

  27. Boeve BF, Lang AE, Litvan I (2003) Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54:S15–S19

    Article  PubMed  Google Scholar 

  28. Eckert T, Barnes A, Dhawan V et al (2005) FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 26:912–921

    Article  PubMed  Google Scholar 

  29. Ketter TA, George MS, Kimbrell TA et al (1996) Functional brain imaging, limbic function and affective disorders. Neuroscientist 2:55–65

    Google Scholar 

  30. Meyer JH (2008) Applying neuroimaging ligands to study major depressive disorder. Semin Nucl Med 38:287–304

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, University of Leipzig, Saxony, Germany

    Osama Sabri, Solveig Tiepolt, Swen Hesse & Henryk Barthel

Authors
  1. Osama Sabri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Solveig Tiepolt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Swen Hesse
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Henryk Barthel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Radiology, University Hospital, Zurich, Switzerland

    J. Hodler

  2. Nuclear Medicine, University Hospital, Zurich, Switzerland

    G. K. von Schulthess

  3. Kilchberg/Zurich, Switzerland

    Ch. L. Zollikofer

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Italia

About this paper

Cite this paper

Sabri, O., Tiepolt, S., Hesse, S., Barthel, H. (2012). PET Imaging of Dementia. In: Hodler, J., von Schulthess, G.K., Zollikofer, C.L. (eds) Diseases of the Brain, Head & Neck, Spine 2012–2015. Springer, Milano. https://doi.org/10.1007/978-88-470-2628-5_35

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2628-5_35

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2627-8

  • Online ISBN: 978-88-470-2628-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation